Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 93

STIPULATION AND ORDER REGARDING POST-MARKMAN SCHEDULE. Motions due by 11/20/2012. Replies due by 1/10/2013. Opposition due by 12/21/2012. Final Pretrial Conference set for 5/17/2013 at 01:30 PM in Courtroom G, 15th Floor, San Francisco. Jury Sele ction set for 6/3/2013 08:30 AM before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/3/2013 08:30 AM in Courtroom G, 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Motion Hearing set for 2/1/2013 09:30 AM in Courtroom G , 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/4/2013 08:30 AM in Courtroom G, 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/5/2013 08:30 AM in Courtroom G, 15th F loor, San Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/6/2013 08:30 AM in Courtroom G, 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/10/2013 08:30 AM in Courtroom G, 15th Floor, S an Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/11/2013 08:30 AM in Courtroom G, 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/12/2013 08:30 AM in Courtroom G, 15th Floor, San Fra ncisco before Magistrate Judge Joseph C. Spero. Jury Trial set for 6/13/2013 08:30 AM in Courtroom G, 15th Floor, San Francisco before Magistrate Judge Joseph C. Spero. Signed, as modified, by Judge Joseph C. Spero on 3/26/12. (klhS, COURT STAFF) (Filed on 3/26/2012)

1

(All parties and counsel listed on Signature Page)

2
3
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

4
5
6
7
8

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

9

Case No. 3:11-cv-00840 JCS
STIPULATION AND [PROPOSED]
ORDER REGARDING POST-MARKMAN
SCHEDULE

Plaintiffs,
Judge:

10
11

v.
HANDA PHARMACEUTICALS, LLC,

12
13
14
15

Defendant.
TAKEDA PHARMACEUTICAL CO., LTD., Case No. 3:11-cv-01609 JCS
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

16

Plaintiffs,

17
18
19

v.
ANCHEN PHARMACEUTICALS, INC., AND
TWI PHARMACEUTICALS, INC.,
Defendants.

20
21
22

Hon. Joseph C. Spero
Courtroom G, 15th Floor

TAKEDA PHARMACEUTICAL CO., LTD., Case No. 3:11-cv-01610 JCS
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

23
Plaintiffs,
24
v.
25
IMPAX LABORATORIES, INC.,
26
Defendant.
27
28
16738288.1

1
2

WHEREAS, the Court issued a Case Management and Pretrial Order on August 29, 2011,
setting forth the schedule with respect to Claim Construction;

3

WHEREAS, the Court did not set post-Markman dates in its order of August 29, 2011;

4

WHEREAS, at the Claim Construction Hearing on February 16, 2012, the Court directed

5

the parties to agree on a schedule for the remainder of pre-trial events;

6
7

WHEREAS, the parties, by their undersigned attorneys, hereby stipulate to the following
schedule, subject to the approval of the Court:

8
9
10
11
12

Event

Date

Document Production Complete for Foreign-Language Documents

Monday, 04/30/12*

Document Production Complete for English-Language Documents

Tuesday, 05/15/12*

Fact Discovery Cut-Off

Friday, 07/27/12

Initial Expert Reports on Issues where party Bears Burden of Proof.
Takeda will provide any report on secondary considerations at this time.

Friday, 08/24/12

14
15

Rebuttal Expert Reports

16

Expert Discovery Cut-Off

17

Last Day to File Dispositive Motions

18

Oppositions Due for Dispositive Motions Filed on November 20, 2012

19

Replies Due for Dispositive Motions Filed on November 20, 2012

20

Motions Hearing

21

Pretrial Conference

Friday, May 17, 2013 at 1:30 PM

22

Trial

June 3, 2013 at 8:30 AM

13

Friday, 9/21/12
Friday, 10/26/12
Tuesday, 11/20/12
Friday, 12/21/12
Friday, 1/10/13
Friday, 02/01/13
Thursday, 03/07/13
March or April 2013

23
24
25
*

26
27
28

The agreed-upon dates for the close of document production relate to documents produced in
response to the comprehensive requests exchanged by the parties last year. The parties
acknowledge that additional Requests for Production that are more narrow in scope, such as
requests seeking individual documents or small populations of documents, may be issued between
now and the close of fact discovery. Furthermore, this agreement is not intended to supersede the
requirements of Rule 34 or other Federal Rules of Civil Procedure.
16738288.1

-2-

1
2

Respectfully Submitted,
DATED: March 21, 2012

3

TAKEDA PHARMACEUTICAL CO., LTD., TAKEDA
PHARMACEUTICALS NORTH AMERICA, INC.,
TAKEDA PHARMACEUTICALS LLC, AND
TAKEDA PHARMACEUTICALS AMERICA, INC.

4
5
By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
ERIN J. COX (SBN 267954)
[e-mail]

6
7
8
9
10

13

MUNGER, TOLLES & OLSON LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]

14

HANDA PHARMACEUTICALS, LLC

11
12

15
16

By:
/s/ Mark T. Jansen
Mark T. Jansen (SBN 114896)
[e-mail]
CROWELL & MORING LLP
275 Battery St., 23rd Fl.
San Francisco, CA 94111
Telephone: [phone]
Facsimile: [phone]

17
18
19
20
21

ANCHEN PHARMACEUTICALS, INC. AND TWI
PHARMACEUTICALS, INC.

22
23

By:
/s/ Don J. Mizerk
Don J. Mizerk (SBN 208477)
[e-mail]
HUSCH BLACKWELL LLP
120 S. Riverside Plaza, Suite 2200
Chicago, IL 60606
Telephone: [phone]
Facsimile: [phone]

24
25
26
27
28
16738288.1

-3-

1

IMPAX LABORATORIES, INC.

2
3

By:
/s/ Eric M. Acker
David C. Doyle (SBN 70690)
[e-mail]
Eric M. Acker (SBN 135805)
[e-mail]
MORRISON & FOERSTER LLP
12531 High Bluff Drive, Suite 100
San Diego, CA 92130-2040
Telephone: [phone]
Facsimile: [phone]

4
5
6
7
8

Brian F. McMahon (SBN 235373)
[e-mail]
MORRISON & FOERSTER LLP
555 W 5th St 35th Fl
Los Angeles, CA 90013
Telephone: [phone]
Facsimile: [phone]

9
10
11
12

Parisa Jorjani (SBN 203487)
[e-mail]
MORRISON & FOERSTER LLP
425 Market Street
San Francisco, CA 94105-2482
P [phone]
F [phone]

13
14
15
16

Attorneys for Defendant
IMPAX LABORATORIES, INC.

17
18

PURSUANT TO STIPULATION, IT IS SO ORDERED.

20

22

ERED
O ORD D
IT IS S
IFIE
D
AS MO

R NIA

UNIT
ED

S

March 26
DATED: ___________, 2012

RT
U
O

THE HONORABLE seph C. Spero C. SPERO
JOSEPH
Jo
Ju MAGISTRATE JUDGE
UNITED STATESdge
RT

ER

H

24

FO

NO

23

LI

21

S DISTRICT
TE
C
TA

25
26
27
28
16738288.1

-4-

A

19

N

F
D IS T IC T O
R

C

1

Filer’s Attestation

2

I, Heather Takahashi, am the ECF user whose identification and password are

3

being used to file this STIPULATION AND [PROPOSED] ORDER REGARDING

4

POST-MARKMAN SCHEDULE. In compliance with General Order 45.X.B, I

5

hereby attest that the other above-named signatory concurs in this filing.

6

DATED: March 21, 2012

7
/s/ Heather E. Takahashi

8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
16738288.1

-5-